MedTrace Logo

Study of the Wearable Defibrillator in Heart-Failure Patients

NCT01326624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-12-06

No results posted yet for this study

Summary

The purpose of the study is to evaluate the safety and efficacy of wearable defibrillator use in patients with left ventricular dysfunction or advanced heart failure symptoms, who have a high-risk for sudden cardiac death but are either not eligible for an implantable defibrillator under current guidelines or are not able to receive the device due to their condition.

Conditions

  • Heart Failure
  • Ventricular Dysfunction
  • Sudden Death
  • Sudden Cardiac Arrest
  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

wearable defibrillator (LifeVest)

LifeVest wearable defibrillator for unattended treatment of sudden cardiac arrest due to ventricular tachycardia or ventricular fibrillation

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Eldar, MD · Chaim Sheba Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01326624 on ClinicalTrials.gov